Announcements Trials
Browse Landscape

Phase

Phase NA 8Phase 4 4Phase 3 1Phase 2 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 5Gynecologic 3Tumor-Agnostic 1Thoracic 1Other neoplasm 1Genitourinary 1Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1

Interventions

Fluorouracil 309Oxaliplatin 260Leucovorin 234Capecitabine 198Irinotecan 147Gemcitabine 128Cisplatin 126Bevacizumab 119Radiotherapy 72Paclitaxel 64Folfox protocol 56Cetuximab 56Drug Therapy 46Sorafenib 45Docetaxel 42S 1 (combination) 40Chemotherapy, Adjuvant 38Neoadjuvant Therapy 37pembrolizumab 36130-nm albumin-bound paclitaxel 29Surgical Procedures, Operative 27regorafenib 25lenvatinib 24XELOX 24Radiation 24Panitumumab 24Nivolumab 23atezolizumab 22Carboplatin 22trifluridine tipiracil drug combination 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Bupivacaine × Gastrointestinal × Clear all
NCT03434678 2025-07-30

Use of Epidurals Intraoperatively for Patients Undergoing Pancreas Resection

Memorial Sloan Kettering Cancer Center

Phase 3 Completed
133 enrolled 6 charts
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡